| 臺大學術典藏 |
2022-06-27T06:59:50Z |
Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists
|
Wang C.-Y.; Lin Y.S.; Wang Y.-H.; Lai C.-C.; Wang H.-C.; Chen L.; CHONG-JEN YU; CHONG-JEN YU; Wang H.-C.; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Tsai Y.-H.; Hsiue T.-R.; Lin M.-C.; Lin H.-I.; Wang C.-Y.; Chang Y.-C.; Yang U.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Wei Y.-F.; Chong I.-W.; Chen C.-Y.; On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) |
| 國家衛生研究院 |
2018-10-09 |
Risk of sepsis and mortality among patients with chronic obstructive pulmonary disease treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
|
Lai, CC;Wang, YH;Wang, CY;Wang, HC;Yu, CJ;Chen, L;on the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases(TCORE) |
| 臺大學術典藏 |
2020-08-12T07:46:57Z |
Risk of Sepsis and Mortality Among Patients With Chronic Obstructive Pulmonary Disease Treated With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers
|
Lai C.-C.; Wang Y.-H.; Wang C.-Y.; HAO-CHIEN WANG; Yu C.-J.; Chen L.; Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) |
| 臺大學術典藏 |
2022-06-27T06:59:57Z |
Risk of Sepsis and Mortality Among Patients With Chronic Obstructive Pulmonary Disease Treated With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers
|
Lai C.-C.; Wang Y.-H.; Wang C.-Y.; Wang H.-C.; CHONG-JEN YU; Chen L.; Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) |
| 國家衛生研究院 |
2018-11-21 |
Risk of sepsis in patients with primary aldosteronism
|
Chan, CK;Hu, YH;Chen, L;Chang, CC;Lin, YF;Lai, TS;Huang, KH;Lin, YH;Wu, VC;Wu, KD;TAIPAI Study Group |
| 臺大學術典藏 |
2019-09-19T04:28:09Z |
Risk of sepsis in patients with primary aldosteronism
|
Wu, Kwan-Dun;VIN-CENT WU;YEN-HUNG LIN;KUO-HOW HUANG;TAI-SHUAN LAI;YU-FENG LIN;Chang, Chin-Chen;Chen, Likwang;Hu, Ya-Hui;Chan, Chieh-Kai; Chan, Chieh-Kai; Hu, Ya-Hui; Chen, Likwang; Chang, Chin-Chen; YU-FENG LIN; TAI-SHUAN LAI; KUO-HOW HUANG; YEN-HUNG LIN; VIN-CENT WU; Wu, Kwan-Dun |
| 臺大學術典藏 |
2020-12-04T07:44:37Z |
Risk of sepsis in patients with primary aldosteronism 11 Medical and Health Sciences 1103 Clinical Sciences
|
Yen R.-F.; Lu C.-C.; Liao S.-C.; Chan C.-K.; Hu Y.-H.; Chen L.; Chang C.-C.; Lin Y.-F.; Lai T.-S.; Huang K.-H.; Lin Y.-H.; Wu V.-C.; Wu K.-D.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Chang C.-H.; Chang Y.-L.; Tsai Y.-C.; Yu C.-C.; Chang H.-W.; LIAN-YU LIN; Hu F.-C.; Wang S.-M. |
| 臺大學術典藏 |
2018 |
Risk of sepsis in patients with primary aldosteronism 11 Medical and Health Sciences 1103 Clinical Sciences
|
YEN-HUNG LIN; Huang K.-H.; Chan C.-K.; Hu Y.-H.; Chen L.; Chang C.-C.; Lin Y.-F.; Lai T.-S.; Wu V.-C.; Wu K.-D.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Chang C.-H.; Chang Y.-L.; Tsai Y.-C.; Yu C.-C.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Wang S.-M.; Liao S.-C.; Lu C.-C.; Yen R.-F. |
| 臺大學術典藏 |
2018 |
Risk of sepsis in patients with primary aldosteronism 11 Medical and Health Sciences 1103 Clinical Sciences
|
Chan C.-K.; Hu Y.-H.; Chen L.; Chang C.-C.; Lin Y.-F.; TAI-SHUAN LAI; Huang K.-H.; Lin Y.-H.; Wu V.-C.; Wu K.-D.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Chang C.-H.; Chang Y.-L.; Tsai Y.-C.; Yu C.-C.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Wang S.-M.; Liao S.-C.; Lu C.-C.; Yen R.-F. |
| 臺大學術典藏 |
2021-08-24T08:01:28Z |
Risk of sepsis in patients with primary aldosteronism 11 Medical and Health Sciences 1103 Clinical Sciences
|
CHIEH-KAI CHAN; Hu Y.-H.; Chen L.; Chang C.-C.; Lin Y.-F.; Lai T.-S.; Huang K.-H.; Lin Y.-H.; Wu V.-C.; Wu K.-D.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Chang C.-H.; Chang Y.-L.; Tsai Y.-C.; Yu C.-C.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Wang S.-M.; Liao S.-C.; Lu C.-C.; Yen R.-F. |
